These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6754419)

  • 1. Inhibition of neurotensin (NT)-induced glucagon release by [D-Trp11]-NT1.
    Ukai M; Itatsu T; Shibata A; Rioux F; St-Pierre S
    Experientia; 1982 Oct; 38(10):1222-4. PubMed ID: 6754419
    [No Abstract]   [Full Text] [Related]  

  • 2. The histaminergic mechanism of neurotensin-induced glucagon release from isolated rat pancreatic islets.
    Itatsu T; Shibata A; Ukai M
    Endocrinol Jpn; 1981 Oct; 28(5):631-5. PubMed ID: 7047156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of neurotensin on insulin, glucagon, and somatostatin release from isolated pancreatic islets.
    Dolais-Kitabgi J; Kitabgi P; Brazeau P; Freychet P
    Endocrinology; 1979 Jul; 105(1):256-60. PubMed ID: 376297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurotensin inhibits glucose but not glucagon-induced insulin and somatostatin release in isolated islets.
    Dolais-Kitabgi J; Freychet P
    Diabete Metab; 1979 Dec; 5(4):275-7. PubMed ID: 44873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the inhibitory effect of [D-Trp11]-NT toward some biological actions of neurotensin in rats.
    Rioux F; Kérouac R; St-Pierre S
    Neuropeptides; 1983 Jul; 3(5):345-54. PubMed ID: 6194472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of adenosine on the serum levels of glucose, insulin and glucagon in vivo.
    Suárez J; Valles VE; Chagoya de Sánchez V
    Int J Biochem; 1987; 19(1):85-8. PubMed ID: 3552779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential endocrine effects of hypothalamic peptide "neurotensin" on pancreas in dogs.
    Kawanishi K; Goto A; Ishida T; Kawamura K; Nishina Y; Machida S; Yamamoto S; Ofuji T
    Acta Med Okayama; 1978 Aug; 32(4):301-8. PubMed ID: 153091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective blockade of neurotensin-induced coronary vessel constriction in perfused rat hearts by a neurotensin analogue.
    Quirion R; Rioux F; Regoli D; St-Pierre S
    Eur J Pharmacol; 1980 Feb; 61(3):309-12. PubMed ID: 7363941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased glucagon secretion in protein-fed rats: effects of refeeding a normal diet.
    Eisenstein AB; Strack I
    Proc Soc Exp Biol Med; 1978 Sep; 158(4):578-81. PubMed ID: 358204
    [No Abstract]   [Full Text] [Related]  

  • 10. Glucose intolerance in thyrotoxic rats: role of insulin, glucagon, and epinephrine.
    Ikeda T; Mokuda O; Tominaga M; Mashiba H
    Am J Physiol; 1988 Dec; 255(6 Pt 1):E843-9. PubMed ID: 3059820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrectomy induces impaired insulin and glucagon secretion: evidence for a gastro-insular axis in mice.
    Salehi A; Chen D; Håkanson R; Nordin G; Lundquist I
    J Physiol; 1999 Jan; 514 ( Pt 2)(Pt 2):579-91. PubMed ID: 9852337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of neurotensin and substance P on plasma insulin, glucagon and glucose levels.
    Brown M; Vale W
    Endocrinology; 1976 Mar; 98(3):819-22. PubMed ID: 1261503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a 5'-substituted adenosine analogue (744c96) on insulin and glucagon release in isolated rat islets of Langerhans.
    Schütz W; Raberger G; Brugger G; Kraupp O
    Arch Int Pharmacodyn Ther; 1979 Jan; 237(1):88-97. PubMed ID: 384948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the oral hypoglycemic agent pirogliride tartrate on insulin and glucagon secretion in vivo and in vitro.
    Tutwiler GJ; Fawthrop HC; Krill RT; Pek S
    Adv Exp Med Biol; 1979; 119():435-41. PubMed ID: 386729
    [No Abstract]   [Full Text] [Related]  

  • 15. Central nervous system-mediated stimulation of glucagon secretion in the dog following 2-deoxyglucose.
    Frohman LA; Nagai K
    Metabolism; 1976 Nov; 25(11 Suppl 1):1449-52. PubMed ID: 790091
    [No Abstract]   [Full Text] [Related]  

  • 16. Centrally administered [D-Trp11]neurotensin, as well as neurotensin protected from inactivation by thiorphan, modifies locomotion in rats in a biphasic manner.
    Nouel D; Dubuc I; Kitabgi P; Costentin J
    Peptides; 1990; 11(3):551-5. PubMed ID: 2381875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A nonsuppressible increase of glucagon secretion by isolated islets of high-protein-fed rats.
    Eisenstein AB; Strack I
    Diabetes; 1976 Jan; 25(1):51-5. PubMed ID: 1107094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of somatostatin on neurotensin-induced glucagon release and hyperglycemia.
    Ukai M; Inoue I; Itatsu T
    Endocrinology; 1977 May; 100(5):1284-6. PubMed ID: 849724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular effects of neurotensin microinjections into the nucleus of the solitary tract.
    Ciriello J; Zhang TX
    Brain Res; 1997 Feb; 749(1):35-43. PubMed ID: 9070625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatostatin, insulin and glucagon secretion by the perfused pancreas from the cysteamine-treated rat.
    Silvestre RA; Miralles P; Moreno P; Villanueva ML; Marco J
    Biochem Biophys Res Commun; 1986 Feb; 134(3):1291-7. PubMed ID: 2868720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.